A. Rempel

发表

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

D. Mayer, P. Bannasch, A. Rempel, 1994, Biochimica et biophysica acta.

Glucose Catabolism in Cancer Cells.

Saroj P. Mathupala, P. Pedersen, S. Mathupala, 1995, The Journal of Biological Chemistry.

Glucose Catabolism in Cancer Cells

Saroj P. Mathupala, P. Pedersen, S. Mathupala, 2001, The Journal of Biological Chemistry.

Glucose catabolism in cancer cells: regulation of the type II hexokinase promoter by glucose and cyclic AMP

P. Pedersen, S. Mathupala, A. Rempel, 1996, FEBS letters.

Microheterogeneity of cytosolic and membrane-bound hexokinase II in Morris hepatoma 3924A.

D. Mayer, P. Bannasch, A. Rempel, 1994, The Biochemical journal.

Hexokinase expression in liver preneoplasia and neoplasia.

D. Mayer, P. Bannasch, F. Klimek, 1997, Biochemical Society transactions.

Glucose catabolism in cancer cells: Role and regulation of hexokinase overexpression

P. Pedersen, S. Mathupala, A. Rempel, 1998 .

Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors

M. Schwarz, P. Bannasch, A. Rempel, 2004, Virchows Archiv.

Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas

Y. Ahn, H. Zerban, P. Bannasch, 2004, Virchows Archiv.

Encoding Type II Hexokinase Glucose Catabolism in Cancer Cells : Amplification of the Gene Updated

P. Pedersen, S. Mathupala, C. Griffin, 2006 .

FHL2, a novel tissue‐specific coactivator of the androgen receptor

R. Schüle, R. Buettner, M. Moser, 2000, The EMBO journal.

Defi ciency in the LIM-only protein Fhl2 impairs skin wound healing

A. Bosserhoff, R. Schüle, R. Buettner, 2007 .

The Oral Serine Protease Inhibitor WX-671 – First Experience in Patients with Advanced Head and Neck Carcinoma

H. Graefe, B. Wollenberg, N. Rotter, 2008, Breast Care.

Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase

Saroj P. Mathupala, P. Pedersen, S. Mathupala, 1997, Journal of bioenergetics and biomembranes.

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Saroj P. Mathupala, P. Pedersen, J. Geschwind, 2002, Biochimica et biophysica acta.

Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase.

P. Pedersen, S. Mathupala, C. Griffin, 1996, Cancer research.